Mar. 3 at 1:39 PM
$SRTA Q4’25 Earnings 🚀
👉Click to view @StockMomentumLab for timely updates amid the volatility.
Q4 Highlights:
Revenue:
$66.8M vs est
$59M, +83.5% YoY
Gross Profit:
$14.4M, +90% YoY
Adj. EBITDA:
$7.0M, +547% YoY
FY26 Guidance:
Revenue:
$260M–
$275M, +40% YoY
Adj. EBITDA:
$29M–
$33M, +118% YoY
Free cash flow:
$15M–
$22M (pre aircraft/engine acquisitions)
Segment Strength:
Logistics:
$49.2M, +35.3% YoY, gross profit
$10.6M, +39.5% YoY
Clinical:
$17.6M
Financial Takeaways:
Q4 Gross Margin: 21.6%, +80bps YoY
FY25 Revenue:
$197.1M; FY25 EBITDA:
$14M — beats high end of guidance
Cash/Short-term investments:
$61.2M
Commentary:
Keystone acquisition driving >40% sequential logistics growth in Q4
Company expects continued execution on acquisitions to maintain 30%+ annualized Adj. EBITDA growth
$SRTA is executing on both organic and acquisition-led growth, showing strong momentum across logistics and clinical segments
